Cargando…
Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease?
Mitochondrial dysfunction is a hallmark of Parkinson’s disease (PD). Astrocytes are the most abundant glial cell type in the brain and are thought to play a pivotal role in the progression of PD. Emerging evidence suggests that many astrocytic functions, including glutamate metabolism, Ca(2+) signal...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849831/ https://www.ncbi.nlm.nih.gov/pubmed/33537300 http://dx.doi.org/10.3389/fcell.2020.608026 |
_version_ | 1783645362614960128 |
---|---|
author | Bantle, Collin M. Hirst, Warren D. Weihofen, Andreas Shlevkov, Evgeny |
author_facet | Bantle, Collin M. Hirst, Warren D. Weihofen, Andreas Shlevkov, Evgeny |
author_sort | Bantle, Collin M. |
collection | PubMed |
description | Mitochondrial dysfunction is a hallmark of Parkinson’s disease (PD). Astrocytes are the most abundant glial cell type in the brain and are thought to play a pivotal role in the progression of PD. Emerging evidence suggests that many astrocytic functions, including glutamate metabolism, Ca(2+) signaling, fatty acid metabolism, antioxidant production, and inflammation are dependent on healthy mitochondria. Here, we review how mitochondrial dysfunction impacts astrocytes, highlighting translational gaps and opening new questions for therapeutic development. |
format | Online Article Text |
id | pubmed-7849831 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78498312021-02-02 Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease? Bantle, Collin M. Hirst, Warren D. Weihofen, Andreas Shlevkov, Evgeny Front Cell Dev Biol Cell and Developmental Biology Mitochondrial dysfunction is a hallmark of Parkinson’s disease (PD). Astrocytes are the most abundant glial cell type in the brain and are thought to play a pivotal role in the progression of PD. Emerging evidence suggests that many astrocytic functions, including glutamate metabolism, Ca(2+) signaling, fatty acid metabolism, antioxidant production, and inflammation are dependent on healthy mitochondria. Here, we review how mitochondrial dysfunction impacts astrocytes, highlighting translational gaps and opening new questions for therapeutic development. Frontiers Media S.A. 2021-01-07 /pmc/articles/PMC7849831/ /pubmed/33537300 http://dx.doi.org/10.3389/fcell.2020.608026 Text en Copyright © 2021 Bantle, Hirst, Weihofen and Shlevkov. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cell and Developmental Biology Bantle, Collin M. Hirst, Warren D. Weihofen, Andreas Shlevkov, Evgeny Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease? |
title | Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease? |
title_full | Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease? |
title_fullStr | Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease? |
title_full_unstemmed | Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease? |
title_short | Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease? |
title_sort | mitochondrial dysfunction in astrocytes: a role in parkinson’s disease? |
topic | Cell and Developmental Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849831/ https://www.ncbi.nlm.nih.gov/pubmed/33537300 http://dx.doi.org/10.3389/fcell.2020.608026 |
work_keys_str_mv | AT bantlecollinm mitochondrialdysfunctioninastrocytesaroleinparkinsonsdisease AT hirstwarrend mitochondrialdysfunctioninastrocytesaroleinparkinsonsdisease AT weihofenandreas mitochondrialdysfunctioninastrocytesaroleinparkinsonsdisease AT shlevkovevgeny mitochondrialdysfunctioninastrocytesaroleinparkinsonsdisease |